In particular, in public database analysis using BreastMark and TCGA data, ESRP1 expression was significantly associated with shorter overall survival in ER-positive, but not ER-negative, breast cancer [21], indicating the subtype-specific prognostic significance of ESRP1 expression. This evidence concerns the gene ESRP1 and breast cancer.